Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 84.00 | |
2 mg | In stock | $ 119.00 | |
5 mg | In stock | $ 197.00 | |
10 mg | In stock | $ 297.00 | |
25 mg | In stock | $ 598.00 | |
50 mg | In stock | $ 853.00 | |
100 mg | In stock | $ 1,180.00 | |
500 mg | In stock | $ 2,350.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 252.00 |
Description | NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively. |
Targets&IC50 | MAP4K2:21.7 nM, TAK1:149 nM |
In vitro | NG25 sensitizes the breast cancer cells to Dox treatment in vitro. This combination may be an effective and feasible therapeutic option maximizing Dox efficacy and meanwhile minimizing Dox side effects in treating breast cancer[1]. |
Cell Research | Breast cancer cells were seeded in 12-well plates at 2?×?10^3 cells per well, then incubated with Dox alone or Dox with NG25 at indicated concentrations after 72?h and then were cultured in fresh medium without drug.?Two weeks later, cells were fixed and stained with methanol/crystal violet for 10?min, and photographed.?Each experiment was performed in triplicates[1]. |
Molecular Weight | 537.58 |
Formula | C29H30F3N5O2 |
CAS No. | 1315355-93-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (186.02 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NG25 1315355-93-1 MAPK NG-25 NG 25 MAP kinase kinase kinase, MEKK, MAPKKK MAP4K inhibit Inhibitor MAP3K MAPK Kinase Kinase Kinase inhibitor